Financials
Financial year 2025
CURAMED from Paliseul, company number BE0787531122, closed financial year 2025 with a result of € 33,703 after tax. For that financial year CURAMED recorded a gross margin of € 46,667 and equity of € 127,465. Compared with financial year 2024, the result moved from € 17,419 to € 33,703. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 2, 2026.
€ 127,465
▲ 36% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,703
▲ 93% vs 2024
Profit after tax over the fiscal year.
€ 90,979
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 118,465.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 380,496
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,377
▼ 24% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 66,617 | € 24,369 | € 23,454 | € 46,667 | ▲ 99% |
| Profit after taxes | € 49,921 | € 17,422 | € 17,419 | € 33,703 | ▲ 93% |
| Equity | € 58,921 | € 76,343 | € 93,762 | € 127,465 | ▲ 36% |
| Total debts | € 435,901 | € 477,555 | € 431,805 | € 389,145 | ▼ 10% |
| Cash | € 184,642 | € 175,118 | € 85,692 | € 90,979 | ▲ 6% |
| Retained profit | € 49,921 | € 67,343 | € 84,762 | € 118,465 | ▲ 40% |
| Balance sheet total | € 494,822 | € 553,898 | € 525,567 | € 516,610 | ▼ 2% |
Key figures of CURAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CURAMED?
What happened at CURAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 33,703 (▲ 93% vs 2024). filed late Source: NBB ↗
- New establishment in Paliseul. KBO
- New establishment in Daverdisse. KBO
- Christophe FORTUNE became a director. NBB
- ERIK DE CLERCK became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 49,921 profit in 2022 to € 33,703 profit in 2025.
Paid € 40,831 in corporate taxes since 2022.
Best year ever: 2022, with € 49,921 profit.
Management
Behind CURAMED are Christophe FORTUNE and ERIK DE CLERCK. ERIK DE CLERCK is also behind De Clerck-Laduron.
Directors
According to the 2025 annual accounts
Christophe FORTUNE
Director
since 2022
since 2022
Establishments
Establishment units
Physical locations of this company
Rue d'Offagne 31 A
6850 Paliseul
Rue de Gedinne, Haut-Fays 43
6929 Daverdisse
Active since 22 June 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0787.531.122
- VAT number
- BE 0787.531.122
- Registered office
- Rue d'Offagne 31 A, 6850 Paliseul
- Names & denominations
- CURAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 June 2022
- Peppol
- Active · Active since 28 Jan 2026
- Activities · NACE
Veterinaire diensten
Ondersteunende activiteiten in verband met de veeteelt